Projects per year
Fingerprint Dive into the research topics where Gerardo Colon-Otero is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 17 Similar Profiles
Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Ovarian Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
African Americans
Medicine & Life Sciences
Appointments and Schedules
Medicine & Life Sciences
20th Century History
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1980 2019
- 1 Finished
CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
David, C. S., Jenkins, R. B., Cunningham, J. M., Wettstein, P. J., Buckner, J. C., Lingle, W. L., Kocher, J., Highsmith, W. E. J., Beebe, T. J., Vile, R. G., Okuno, S. H., Sarkaria, J. N., Alberts, S. R., Salisbury, J. L., Van Deursen, J., Diasio, R. B., Sargent, D. J., Thibodeau, S. N., Ingle, J. N., Reid, J. M., Colon-Otero, G., Galanis, E., Weinshilboum, R. M., Jenkins, R. B., Banks, P., Flotte, T., Kwon, E. D., Federspiel, M. J., Pitot, H. C., Dewald, G., Held, K., Liebson, P., Banks, P., Prendergast, F., Weiland, L., Wiebeu, E., Moertel, C., Clapham, D., Burnham, N., O'Connell, M., Spelsburg, T., Maihle, N., Katzmann, J., Wieand, H., Kovach, J., Wold, L., Grendahl, D., McCormick, D., Leibson, P., O'Fallon, J., Ames, M., Kline, B., Prendergast, F., Adjei, A., Chute, C., McKean, D., Highsmith, E., Raghavakaimal, S., Pitot, H., Greipp, P., Wieben, E., Roche, P., Leibson, P., Lawson, M., Grendahl, D., McCormick, D., Ames, M., Wieben, E. D., Flotte, T. J., Adjei, A. & Greipp, P. T.
3/1/80 → 2/28/19
Project: Research project
Neoplasms
Research
Research Personnel
Cytogenetics
Biostatistics
Research Output 1981 2019
- 2075 Citations
- 23 Scopus h-Index
- 73 Article
Constitutively active ESR1 mutations in gynecologic malignancies and clinical response to estrogen-receptor directed therapies
Gaillard, S. L., Andreano, K. J., Gay, L. M., Steiner, M., Jorgensen, M. S., Davidson, B. A., Havrilesky, L. J., Alvarez Secord, A., Valea, F. A., Colon-Otero, G., Zajchowski, D. A., Chang, C. Y., McDonnell, D. P., Berchuck, A. & Elvin, J. A., Jan 1 2019, In : Gynecologic oncology.Research output: Contribution to journal › Article
Estrogen Receptors
Mutation
Neoplasms
Therapeutics
Aromatase Inhibitors
Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials
Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.Research output: Contribution to journal › Article
Breast Neoplasms
adjuvant P40
B 31
Trastuzumab
2
Citations
(Scopus)
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination with Pembrolizumab in Patients with Recurrent Platinum-Resistant Ovarian Carcinoma
Konstantinopoulos, P. A., Waggoner, S., Vidal, G. A., Mita, M., Moroney, J. W., Holloway, R., Van Le, L., Sachdev, J. C., Chapman-Davis, E., Colon-Otero, G., Penson, R. T., Matulonis, U. A., Kim, Y. B., Moore, K. N., Swisher, E. M., Färkkilä, A., D'Andrea, A., Stringer-Reasor, E., Wang, J., Buerstatte, N. & 5 others, , Jan 1 2019, In : JAMA Oncology.Research output: Contribution to journal › Article
Platinum
Carcinoma
Triple Negative Breast Neoplasms
pembrolizumab
niraparib
CDKN2A germline rare coding variants and risk of pancreatic cancer in minority populations
Mc Williams, R. R., Wieben, E. D., Chaffee, K. G., Antwi, S., Raskin, L., Olopade, O. I., Li, D., Highsmith, W. E. J., Colon-Otero, G., Khanna, L. G., Permuth, J. B., Olson, J. E., Frucht, H., Genkinger, J., Zheng, W., Blot, W. J., Wu, L., Almada, L. L., Fernandez-Zapico, M. E., Sicotte, H. & 2 others, , Nov 1 2018, In : Cancer Epidemiology Biomarkers and Prevention. 27, 11, p. 1364-1370 7 p.Research output: Contribution to journal › Article
Pancreatic Neoplasms
African Americans
Population
Odds Ratio
Confidence Intervals
1
Citation
(Scopus)
Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
Norton, N., Fox, N., McCarl, C. A., Tenner, K. S., Ballman, K., Erskine, C. L., Necela, B. M., Northfelt, D. W., Tan, W., Calfa, C., Pegram, M., Colon-Otero, G., Perez, E. A., Clynes, R. & Knutson, K. L., Jun 14 2018, In : Breast Cancer Research. 20, 1, 52.Research output: Contribution to journal › Article
Immunity
Breast Neoplasms
Recurrence
Antibodies
Disease-Free Survival